{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:32:16Z","timestamp":1795120336269,"version":"4.10.3"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31830022"],"award-info":[{"award-number":["31830022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621001"],"award-info":[{"award-number":["81621001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830002"],"award-info":[{"award-number":["81830002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773248"],"award-info":[{"award-number":["81773248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773248"],"award-info":[{"award-number":["81773248"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81830002"],"award-info":[{"award-number":["81830002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"publisher","award":["2019YFA0508500"],"award-info":[{"award-number":["2019YFA0508500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Res"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell-mediated cancer clearance is often suppressed by the interaction between inhibitory molecules like PD-1 and PD-L1, an interaction acts like brakes to prevent T cell overreaction under normal conditions but is exploited by tumor cells to escape the immune surveillance. Immune checkpoint inhibitors have revolutionized cancer therapeutics by removing such brakes. Unfortunately, only a minority of cancer patients respond to immunotherapies presumably due to inadequate immunity. Antitumor immunity depends on the activation of the cGAS-STING pathway, as STING-deficient mice fail to stimulate tumor-infiltrating dendritic cells (DCs) to activate CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. STING agonists also enhance natural killer (NK) cells to mediate the clearance of CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell-resistant tumors. Therefore STING agonists have been intensively sought after. We previously discovered that manganese (Mn) is indispensable for the host defense against cytosolic dsDNA by activating cGAS-STING. Here we report that Mn is also essential in innate immune sensing of tumors and enhances adaptive immune responses against tumors. Mn-insufficient mice had significantly enhanced tumor growth and metastasis, with greatly reduced tumor-infiltrating CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Mechanically, Mn\n                    <jats:sup>2+<\/jats:sup>\n                    promoted DC and macrophage maturation and tumor-specific antigen presentation, augmented CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell differentiation, activation and NK cell activation, and increased memory CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Combining Mn\n                    <jats:sup>2+<\/jats:sup>\n                    with immune checkpoint inhibition synergistically boosted antitumor efficacies and reduced the anti-PD-1 antibody dosage required in mice. Importantly, a completed phase 1 clinical trial with the combined regimen of Mn\n                    <jats:sup>2+<\/jats:sup>\n                    and anti-PD-1 antibody showed promising efficacy, exhibiting type I IFN induction, manageable safety and revived responses to immunotherapy in most patients with advanced metastatic solid tumors. We propose that this combination strategy warrants further clinical translation.\n                  <\/jats:p>","DOI":"10.1038\/s41422-020-00395-4","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T10:03:08Z","timestamp":1598263388000},"page":"966-979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":989,"title":["Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8509-7969","authenticated-orcid":false,"given":"Mengze","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9312-0164","authenticated-orcid":false,"given":"Yukun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiejie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaichao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xurui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Cai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3207-3899","authenticated-orcid":false,"given":"Weidong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1247-1382","authenticated-orcid":false,"given":"Zhengfan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,24]]},"reference":[{"key":"395_CR1","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/j.1460-2075.1992.tb05481.x","volume":"11","author":"Y Ishida","year":"1992","unstructured":"Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887\u20133895 (1992).","journal-title":"EMBO J."},{"key":"395_CR2","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","volume":"114","author":"M Ahmadzadeh","year":"2009","unstructured":"Ahmadzadeh, M. et al. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114, 1537\u20131544 (2009).","journal-title":"Blood"},{"key":"395_CR3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027\u20131034 (2000).","journal-title":"J. Exp. Med."},{"key":"395_CR4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","volume":"375","author":"VA Boussiotis","year":"2016","unstructured":"Boussiotis, V. A. Molecular and biochemical aspects of the PD-1 checkpoint pathway. N. Engl. J. Med. 375, 1767\u20131778 (2016).","journal-title":"N. Engl. J. Med."},{"key":"395_CR5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian, S. L., Drake, C. G. & Pardoll, D. M. Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27, 450\u2013461 (2015).","journal-title":"Cancer Cell"},{"key":"395_CR6","doi-asserted-by":"crossref","first-page":"eaaz2738","DOI":"10.1126\/sciimmunol.aaz2738","volume":"5","author":"CJ Nicolai","year":"2020","unstructured":"Nicolai, C. J. et al. NK cells mediate clearance of CD8(+) T cell-resistant tumors in response to STING agonists. Sci. Immunol. 5, eaaz2738 (2020).","journal-title":"Sci. Immunol."},{"key":"395_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","volume":"545","author":"AC Huang","year":"2017","unstructured":"Huang, A. C. et al. T-cell invigoration to tumour burden ratio associated with anti-PD-1 response. Nature 545, 60\u201365 (2017).","journal-title":"Nature"},{"key":"395_CR8","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1001\/jama.2016.4059","volume":"315","author":"A Ribas","year":"2016","unstructured":"Ribas, A. et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315, 1600\u20131609 (2016).","journal-title":"JAMA"},{"key":"395_CR9","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.immuni.2018.09.016","volume":"49","author":"A Marcus","year":"2018","unstructured":"Marcus, A. et al. Tumor-derived cGAMP triggers a STING-mediated interferon response in non-tumor cells to activate the NK cell response. Immunity 49, 754\u2013763 (2018).","journal-title":"Immunity"},{"key":"395_CR10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","volume":"6","author":"GP Dunn","year":"2005","unstructured":"Dunn, G. P. et al. A critical function for type I interferons in cancer immunoediting. Nat. Immunol. 6, 722\u2013729 (2005).","journal-title":"Nat. Immunol."},{"key":"395_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nri3845","volume":"15","author":"L Zitvogel","year":"2015","unstructured":"Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Type I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405\u2013414 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"395_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.smim.2010.04.007","volume":"22","author":"TW Dubensky Jr.","year":"2010","unstructured":"Dubensky, T. W. Jr. & Reed, S. G. Adjuvants for cancer vaccines. Semin. Immunol. 22, 155\u2013161 (2010).","journal-title":"Semin. Immunol."},{"key":"395_CR13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843\u2013852 (2014).","journal-title":"Immunity"},{"key":"395_CR14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830\u2013842 (2014).","journal-title":"Immunity"},{"key":"395_CR15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.it.2015.02.003","volume":"36","author":"SR Woo","year":"2015","unstructured":"Woo, S. R., Corrales, L. & Gajewski, T. F. The STING pathway and the T cell-inflamed tumor microenvironment. Trends Immunol. 36, 250\u2013256 (2015).","journal-title":"Trends Immunol."},{"key":"395_CR16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/ni.3558","volume":"17","author":"Q Chen","year":"2016","unstructured":"Chen, Q., Sun, L. & Chen, Z. J. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing. Nat. Immunol. 17, 1142\u20131149 (2016).","journal-title":"Nat. Immunol."},{"key":"395_CR17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.1621363114","volume":"114","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. cGAS is essential for the antitumor effect of immune checkpoint blockade. Proc. Natl. Acad. Sci. USA 114, 1637\u20131642 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"395_CR18","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/1078-0432.CCR-15-1362","volume":"21","author":"L Corrales","year":"2015","unstructured":"Corrales, L. & Gajewski, T. F. Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer. Clin. Cancer Res. 21, 4774\u20134779 (2015).","journal-title":"Clin. Cancer Res."},{"key":"395_CR19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors. J. Exp. Med. 208, 1989\u20132003 (2011).","journal-title":"J. Exp. Med."},{"key":"395_CR20","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","volume":"208","author":"MB Fuertes","year":"2011","unstructured":"Fuertes, M. B. et al. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells. J. Exp. Med. 208, 2005\u20132016 (2011).","journal-title":"J. Exp. Med."},{"key":"395_CR21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","volume":"564","author":"JM Ramanjulu","year":"2018","unstructured":"Ramanjulu, J. M. et al. Design of amidobenzimidazole STING receptor agonists with systemic activity. Nature 564, 439\u2013443 (2018).","journal-title":"Nature"},{"key":"395_CR22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1084\/jem.20180139","volume":"215","author":"T Li","year":"2018","unstructured":"Li, T. & Chen, Z. J. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer. J. Exp. Med. 215, 1287\u20131299 (2018).","journal-title":"J. Exp. Med."},{"key":"395_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-nutr-071714-034419","volume":"35","author":"KJ Horning","year":"2015","unstructured":"Horning, K. J., Caito, S. W., Tipps, K. G., Bowman, A. B. & Aschner, M. Mn is essential for neuronal health. Annu. Rev. Nutr. 35, 71\u2013108 (2015).","journal-title":"Annu. Rev. Nutr."},{"key":"395_CR24","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.3390\/ijerph120707519","volume":"12","author":"GF Kwakye","year":"2015","unstructured":"Kwakye, G. F., Paoliello, M. M., Mukhopadhyay, S., Bowman, A. B. & Aschner, M. Mn-induced parkinsonism and parkinson\u2019s disease: shared and distinguishable features. Int. J. Environ. Res. Public Health 12, 7519\u20137540 (2015).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"395_CR25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nature08300","volume":"460","author":"KJ Waldron","year":"2009","unstructured":"Waldron, K. J., Rutherford, J. C., Ford, D. & Robinson, N. J. Metalloproteins and metal sensing. Nature 460, 823\u2013830 (2009).","journal-title":"Nature"},{"key":"395_CR26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.immuni.2018.03.017","volume":"48","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses. Immunity 48, 675\u2013687. e677 (2018).","journal-title":"Immunity"},{"key":"395_CR27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature25437","volume":"554","author":"K Mao","year":"2018","unstructured":"Mao, K. et al. Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature 554, 255\u2013259 (2018).","journal-title":"Nature"},{"key":"395_CR28","doi-asserted-by":"crossref","first-page":"e12819","DOI":"10.1111\/cmi.12819","volume":"20","author":"SY Gun","year":"2018","unstructured":"Gun, S. Y. et al. Interferon regulatory factor 1 is essential for pathogenic CD8+ T cell migration and retention in the brain during experimental cerebral malaria. Cell Microbiol. 20, e12819 (2018).","journal-title":"Cell Microbiol."},{"key":"395_CR29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1074-7613(00)80527-0","volume":"7","author":"JM Penninger","year":"1997","unstructured":"Penninger, J. M. et al. The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 7, 243\u2013254 (1997).","journal-title":"Immunity"},{"key":"395_CR30","doi-asserted-by":"crossref","first-page":"15818","DOI":"10.1073\/pnas.2636938100","volume":"100","author":"BM Sullivan","year":"2003","unstructured":"Sullivan, B. M., Juedes, A., Szabo, S. J., von Herrath, M. & Glimcher, L. H. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100, 15818\u201315823 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"395_CR31","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1201730","volume":"190","author":"AP Sutherland","year":"2013","unstructured":"Sutherland, A. P. et al. IL-21 promotes CD8+ CTL activity via the transcription factor T-bet. J. Immunol. 190, 3977\u20133984 (2013).","journal-title":"J. Immunol."},{"key":"395_CR32","doi-asserted-by":"crossref","first-page":"12123","DOI":"10.1073\/pnas.1201453109","volume":"109","author":"F Miyagawa","year":"2012","unstructured":"Miyagawa, F. et al. Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells. Proc. Natl. Acad. Sci. USA 109, 12123\u201312128 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"395_CR33","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1126\/science.1065543","volume":"295","author":"SJ Szabo","year":"2002","unstructured":"Szabo, S. J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295, 338\u2013342 (2002).","journal-title":"Science"},{"key":"395_CR34","volume":"4","author":"G Hu","year":"2013","unstructured":"Hu, G. & Chen, J. A genome-wide regulatory network identifies key transcription factors for memory CD8(+) T-cell development. Nat. Commun. 4, 2830 (2013).","journal-title":"Nat. Commun."},{"key":"395_CR35","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.trecan.2017.04.001","volume":"3","author":"M Arias","year":"2017","unstructured":"Arias, M. et al. The untold story of granzymes in oncoimmunology: novel opportunities with old acquaintances. Trends Cancer 3, 407\u2013422 (2017).","journal-title":"Trends Cancer"},{"key":"395_CR36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2015.10.041","volume":"150","author":"GW Tew","year":"2016","unstructured":"Tew, G. W. et al. Association between response to etrolizumab and expression of integrin alphaE and granzyme A in colon biopsies of patients with ulcerative colitis. Gastroenterology 150, 477\u2013487 (2016).","journal-title":"Gastroenterology"},{"key":"395_CR37","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","volume":"20","author":"A Sistigu","year":"2014","unstructured":"Sistigu, A. et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nat. Med. 20, 1301\u20131309 (2014).","journal-title":"Nat. Med."},{"key":"395_CR38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nri3156","volume":"12","author":"O Boyman","year":"2012","unstructured":"Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180\u2013190 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"395_CR39","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.4049\/jimmunol.1303417","volume":"193","author":"MM Tiemessen","year":"2014","unstructured":"Tiemessen, M. M. et al. T Cell factor 1 represses CD8+ effector T cell formation and function. J. Immunol. 193, 5480\u20135487 (2014).","journal-title":"J. Immunol."},{"key":"395_CR40","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.4049\/jimmunol.1602010","volume":"198","author":"R Singh","year":"2017","unstructured":"Singh, R. et al. Egr2 and 3 Inhibit T-bet-Mediated IFN-gamma Production in T Cells. J. Immunol. 198, 4394\u20134402 (2017).","journal-title":"J. Immunol."},{"key":"395_CR41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4049\/jimmunol.0900939","volume":"183","author":"MM Curtis","year":"2009","unstructured":"Curtis, M. M., Way, S. S. & Wilson, C. B. IL-23 promotes the production of IL-17 by antigen-specific CD8 T cells in the absence of IL-12 and type-I interferons. J. Immunol. 183, 381\u2013387 (2009).","journal-title":"J. Immunol."},{"key":"395_CR42","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.celrep.2018.01.072","volume":"22","author":"M Danilo","year":"2018","unstructured":"Danilo, M., Chennupati, V., Silva, J. G., Siegert, S. & Held, W. Suppression of Tcf1 by inflammatory cytokines facilitates effector CD8 T cell differentiation. Cell Rep. 22, 2107\u20132117 (2018).","journal-title":"Cell Rep."},{"key":"395_CR43","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.4049\/jimmunol.160.7.3236","volume":"160","author":"JM Curtsinger","year":"1998","unstructured":"Curtsinger, J. M., Lins, D. C. & Mescher, M. F. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR\/CD8 signaling in response to antigen. J. Immunol. 160, 3236\u20133243 (1998).","journal-title":"J. Immunol."},{"key":"395_CR44","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1128\/MCB.16.5.2283","volume":"16","author":"JS Maltzman","year":"1996","unstructured":"Maltzman, J. S., Carman, J. A. & Monroe, J. G. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16, 2283\u20132294 (1996).","journal-title":"Mol. Cell. Biol."},{"key":"395_CR45","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","volume":"19","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity. Nat. Immunol. 19, 723\u2013732 (2018).","journal-title":"Nat. Immunol."},{"key":"395_CR46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","volume":"20","author":"ND Huntington","year":"2020","unstructured":"Huntington, N. D., Cursons, J. & Rautela, J. The cancer-natural killer cell immunity cycle. Nat. Rev. Cancer 20, 437\u2013454\u00a0(2020).","journal-title":"Nat. Rev. Cancer"},{"key":"395_CR47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature03847","volume":"436","author":"S Kim","year":"2005","unstructured":"Kim, S. et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709\u2013713 (2005).","journal-title":"Nature"},{"key":"395_CR48","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0041-008X(83)90174-6","volume":"70","author":"RR Rogers","year":"1983","unstructured":"Rogers, R. R., Garner, R. J., Riddle, M. M., Luebke, R. W. & Smialowicz, R. J. Augmentation of murine natural killer cell activity by Mn chloride. Toxicol. Appl. Pharm. 70, 7\u201317 (1983).","journal-title":"Toxicol. Appl. Pharm."},{"key":"395_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08923978409026455","volume":"6","author":"RJ Smialowicz","year":"1984","unstructured":"Smialowicz, R. J. et al. Mn chloride enhances murine cell-mediated cytotoxicity: effects on natural killer cells. J. Immunopharmacol. 6, 1\u201323 (1984).","journal-title":"J. Immunopharmacol."},{"key":"395_CR50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley, R. M., Killeen, N. & Lenardo, M. J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487\u2013501 (2001).","journal-title":"Cell"},{"key":"395_CR51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1084\/jem.182.2.389","volume":"182","author":"F Sallusto","year":"1995","unstructured":"Sallusto, F., Cella, M., Danieli, C. & Lanzavecchia, A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J. Exp. Med. 182, 389\u2013400 (1995).","journal-title":"J. Exp. Med."},{"key":"395_CR52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"Wang, G. et al. Targeting YAP-Dependent MDSC infiltration impairs tumor progression. Cancer Discov. 6, 80\u201395 (2016).","journal-title":"Cancer Discov."},{"key":"395_CR53","volume":"8","author":"H Liang","year":"2017","unstructured":"Liang, H. et al. Host STING-dependent MDSC mobilization drives extrinsic radiation resistance. Nat. Commun. 8, 1736 (2017).","journal-title":"Nat. Commun."},{"key":"395_CR54","first-page":"283ra252","volume":"7","author":"J Fu","year":"2015","unstructured":"Fu, J. et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade. Sci. Transl. Med. 7, 283ra252 (2015).","journal-title":"Sci. Transl. Med."},{"key":"395_CR55","doi-asserted-by":"crossref","first-page":"15408","DOI":"10.1073\/pnas.1512832112","volume":"112","author":"O Demaria","year":"2015","unstructured":"Demaria, O. et al. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proc. Natl. Acad. Sci. USA 112, 15408\u201315413 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"395_CR56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2051-1426-2-3","volume":"2","author":"S Spranger","year":"2014","unstructured":"Spranger, S. et al. Mechanism of tumor rejection with doublets of CTLA-4, PD-1\/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8(+) T cells directly within the tumor microenvironment. J. Immunother. Cancer 2, 3 (2014).","journal-title":"J. Immunother. Cancer"},{"key":"395_CR57","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa072488","volume":"358","author":"A Stepens","year":"2008","unstructured":"Stepens, A. et al. A Parkinsonian syndrome in methcathinone users and the role of Mn. N. Engl. J. Med. 358, 1009\u20131017 (2008).","journal-title":"N. Engl. J. Med."},{"key":"395_CR58","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1021\/acsnano.9b06111","volume":"14","author":"L Hou","year":"2020","unstructured":"Hou, L. et al. Mn-based nanoactivator optimizes cancer immunotherapy via enhancing innate immunity. ACS Nano 14, 3927\u20133940 (2020).","journal-title":"ACS Nano"},{"key":"395_CR59","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-06-3757","volume":"67","author":"A Wallace","year":"2007","unstructured":"Wallace, A. et al. The vascular disrupting agent, DMXAA, directly activates dendritic cells through a MyD88-independent mechanism and generates antitumor cytotoxic T lymphocytes. Cancer Res. 67, 7011\u20137019 (2007).","journal-title":"Cancer Res."},{"key":"395_CR60","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/ijc.21005","volume":"116","author":"L Zhao","year":"2005","unstructured":"Zhao, L., Ching, L. M., Kestell, P., Kelland, L. R. & Baguley, B. C. Mechanisms of tumor vascular shutdown induced by 5,6-dimethylxanthenone-4-acetic acid (DMXAA): increased tumor vascular permeability. Int. J. Cancer 116, 322\u2013326 (2005).","journal-title":"Int. J. Cancer"},{"key":"395_CR61","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cell.2013.07.023","volume":"154","author":"P Gao","year":"2013","unstructured":"Gao, P. et al. Structure-function analysis of STING activation by c[G(2\u2019,5\u2019)pA(3\u2019,5\u2019)p] and targeting by antiviral DMXAA. Cell 154, 748\u2013762 (2013).","journal-title":"Cell"},{"key":"395_CR62","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.4049\/jimmunol.1300097","volume":"190","author":"J Conlon","year":"2013","unstructured":"Conlon, J. et al. Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid. J. Immunol. 190, 5216\u20135225 (2013).","journal-title":"J. Immunol."},{"key":"395_CR63","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1093\/nar\/gkaa084","volume":"48","author":"RM Hooy","year":"2020","unstructured":"Hooy, R. M., Massaccesi, G., Rousseau, K. E., Chattergoon, M. A. & Sohn, J. Allosteric coupling between Mn2+ and dsDNA controls the catalytic efficiency and fidelity of cGAS. Nucleic Acids Res. 48, 4435\u20134447 (2020).","journal-title":"Nucleic Acids Res."},{"key":"395_CR64","doi-asserted-by":"crossref","unstructured":"Zhao, Z. et al. Mn2+ directly activates cGAS and structural analysis suggests Mn2+ induces a noncanonical catalytic synthesis of 2\u20193\u2019-cGAMP. Cell Reports 32 (2020). (In press).","DOI":"10.1016\/j.celrep.2020.108053"},{"key":"395_CR65","first-page":"89","volume":"37","author":"CL Keen","year":"2000","unstructured":"Keen, C. L., Ensunsa, J. L. & Clegg, M. S. Mn metabolism in animals and humans including the toxicity of Mn. Met. Ions Biol. Syst. 37, 89\u2013121 (2000).","journal-title":"Met. Ions Biol. Syst."},{"key":"395_CR66","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/15287398009529844","volume":"6","author":"GL Rehnberg","year":"1980","unstructured":"Rehnberg, G. L., Hein, J. F., Carter, S. D. & Laskey, J. W. Chronic Mn oxide administration to preweanling rats: Mn accumulation and distribution. J. Toxicol. Environ. Health 6, 217\u2013226 (1980).","journal-title":"J. Toxicol. Environ. Health"},{"key":"395_CR67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuro.2014.01.010","volume":"41","author":"AB Bowman","year":"2014","unstructured":"Bowman, A. B. & Aschner, M. Considerations on Mn (Mn) treatments for in vitro studies. Neurotoxicology 41, 141\u2013142 (2014).","journal-title":"Neurotoxicology"},{"key":"395_CR68","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.scitotenv.2011.07.003","volume":"409","author":"RW Leggett","year":"2011","unstructured":"Leggett, R. W. A biokinetic model for Mn. Sci. Total Environ. 409, 4179\u20134186 (2011).","journal-title":"Sci. Total Environ."},{"key":"395_CR69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3181\/00379727-202-43518","volume":"202","author":"CD Davis","year":"1993","unstructured":"Davis, C. D., Zech, L. & Greger, J. L. Mn metabolism in rats: an improved methodology for assessing gut endogenous losses. Proc. Soc. Exp. Biol. Med. 202, 103\u2013108 (1993).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"395_CR70","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0021-9681(66)90094-4","volume":"19","author":"HA Schroeder","year":"1966","unstructured":"Schroeder, H. A., Balassa, J. J. & Tipton, I. H. Essential trace metals in man: Mn. A study in homeostasis. J. Chronic Dis. 19, 545\u2013571 (1966).","journal-title":"J. Chronic Dis."},{"key":"395_CR71","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd.2018.210","volume":"17","author":"J Tang","year":"2018","unstructured":"Tang, J. et al. Trial watch: the clinical trial landscape for PD1\/PDL1 immune checkpoint inhibitors. Nat. Rev. Drug Discov. 17, 854\u2013855 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"395_CR72","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi, L. et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med. 378, 2078\u20132092 (2018).","journal-title":"N. Engl. J. Med."},{"key":"395_CR73","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3389\/fimmu.2019.01654","volume":"10","author":"JW Opzoomer","year":"2019","unstructured":"Opzoomer, J. W., Sosnowska, D., Anstee, J. E., Spicer, J. F. & Arnold, J. N. Cytotoxic chemotherapy as an immune stimulus: a molecular perspective on turning up the immunological heat on cancer. Front. Immunol. 10, 1654 (2019).","journal-title":"Front. Immunol."},{"key":"395_CR74","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","volume":"175","author":"MF Sanmamed","year":"2018","unstructured":"Sanmamed, M. F. & Chen, L. A paradigm shift in cancer immunotherapy: from enhancement to normalization. Cell 175, 313\u2013326 (2018).","journal-title":"Cell"},{"key":"395_CR75","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","volume":"16","author":"F Martins","year":"2019","unstructured":"Martins, F. et al. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance. Nat. Rev. Clin. Oncol.\u00a016, 563\u2013580 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"395_CR76","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.it.2019.04.002","volume":"40","author":"KE Pauken","year":"2019","unstructured":"Pauken, K. E., Dougan, M., Rose, N. R., Lichtman, A. H. & Sharpe, A. H. Adverse events following cancer immunotherapy: obstacles and opportunities. Trends Immunol. 40, 511\u2013523 (2019).","journal-title":"Trends Immunol."},{"key":"395_CR77","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.cell.2011.09.022","volume":"147","author":"H Chen","year":"2011","unstructured":"Chen, H. et al. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147, 436\u2013446 (2011).","journal-title":"Cell"},{"key":"395_CR78","doi-asserted-by":"crossref","first-page":"8653","DOI":"10.1073\/pnas.0900850106","volume":"106","author":"W Sun","year":"2009","unstructured":"Sun, W. et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proc. Natl. Acad. Sci. USA 106, 8653\u20138658 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"395_CR79","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ni.1815","volume":"10","author":"F You","year":"2009","unstructured":"You, F. et al. PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat. Immunol. 10, 1300\u20131308 (2009).","journal-title":"Nat. Immunol."},{"key":"395_CR80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0092-8674(02)00827-9","volume":"110","author":"K Kobayashi","year":"2002","unstructured":"Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191\u2013202 (2002).","journal-title":"Cell"},{"key":"395_CR81","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ni1207","volume":"6","author":"Z Jiang","year":"2005","unstructured":"Jiang, Z. et al. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6, 565\u2013570 (2005).","journal-title":"Nat. Immunol."}],"container-title":["Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41422-020-00395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-020-00395-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41422-020-00395-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T02:37:11Z","timestamp":1696559831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41422-020-00395-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,24]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["395"],"URL":"https:\/\/doi.org\/10.1038\/s41422-020-00395-4","relation":{},"ISSN":["1001-0602","1748-7838"],"issn-type":[{"value":"1001-0602","type":"print"},{"value":"1748-7838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,24]]},"assertion":[{"value":"27 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}